![Lars Grundemar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Lars Grundemar is currently the Director at Reccan Diagnostics AB. He was previously the Chief Executive Officer at Oncorena AB and Oncorena Holding AB.
Lars Grundemar active positions
| Companies | Position | Start |
|---|---|---|
Reccan Diagnostics AB
 Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Director/Board Member | - |
Former positions of Lars Grundemar
| Companies | Position | End |
|---|---|---|
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Chief Executive Officer | 20/06/2022 |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
5
1st degree connections
3
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Develops a novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Oncorena Holding AB
Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Develops novel pharmacological treatment for metastasing clear cell renal cancer | Health Technology |
Reccan Diagnostics AB
Reccan Diagnostics AB Pharmaceuticals: MajorHealth Technology Provides cancer diagnosis and treatment | Health Technology |
- Stock Market
- Insiders
- Lars Grundemar
